Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic intravenous fibrinogen dose comparison in posterior spinal fusion surgery
IRCT20210415050983N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Fibrinogen human in Lumbar disc disorder (LDD) (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Intraoperative bleeding rate. Started May 2023; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
Lumbar disc disorder (LDD)
Beyond the preview
Go deeper on IRCT20210415050983N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050983N3.